Exercise News and Research

Latest Exercise News and Research

ExonHit Therapeutics to take part in MAPT study for early detection of Alzheimer’s disease

ExonHit Therapeutics (Paris:ALEHT) together with Toulouse University Hospital and l’Institut de Recherche Pierre Fabre (IRPF) will participate in the Multidomain Alzheimer Preventive Trial (MAPT). The study’s main objective is to assess the efficacy of a multidomain (nutrition, physical exercise, cognitive stimulation) intervention associated with an omega-3 treatment in preventing the decline of cognitive functions in aged and frail individuals.

2 Nov 2009

Obese Britons suffer the real cost of obesity in every area of their lives, says new study

Half of Britain's obese are seriously damaging their wealth prospects as well as their health, a new study has revealed.

1 Nov 2009

American HomePatient signs fourth forbearance agreement

American HomePatient, Inc. (OTCBB: AHOM), one of the nation’s largest home health care providers, today announced that it has entered into a fourth forbearance agreement with NexBank, SSB, the agent for its senior debt (the “Agent”), and the holders in interest of a majority of the senior debt (the “Forbearance Holders”).

31 Oct 2009

Shire announces third quarter 2009 financial results

Shire plc, the global specialty biopharmaceutical company, announces results for the three months to September 30, 2009.

31 Oct 2009

iCo Therapeutics announces $4,000,000 brokered private placement

iCo Therapeutics Inc. (the "Company") is pleased to announce that further to its press release issued October 20, 2009 announcing a $4,000,000 brokered private placement (the "Offering") co-led by Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents"), the Company has completed the first tranche of the Offering through the issuance of 6,000,000 common shares of Company (the "Shares"). The Shares were issued at a price of $0.48 per share for gross proceeds of $2,880,000.

31 Oct 2009

FDA approves an expanded indication for BYETTA injection

Amylin Pharmaceuticals, Inc., and Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for BYETTA® (exenatide) injection. BYETTA is now approved for use as a stand-alone medication (monotherapy) along with diet and exercise to improve glycemic control in adults with type 2 diabetes.

31 Oct 2009

Individualized MicroNutrient Testing for patients

In response to the current trend toward personalized medicine, the Beaumont Weight Control Center, affiliated with Beaumont Hospitals, a major Detroit-area health system, now offers individualized MicroNutrient Testing for patients.

31 Oct 2009

Cardio Infrared Technologies receives new orders for Commercial Cardio Cor and Personal Cardio Cor II bikes

Cardio Infrared Technologies, Inc., a leading Health and Wellness technology and marketing company, announced today that it has received orders from a new Florida-based client for two of the Commercial Cardio Cor bikes and six Personal Cardio Cor II™ bikes.

30 Oct 2009

Walnut Village, a full-service retirement community, officially opens its door to Anaheim residents

Walnut Village, a new, full-service retirement community in the heart of Anaheim, Calif., officially opened to its first residents this month.

30 Oct 2009

Smartphones for diabetic patients

Cellular phones - once a luxury used strictly for talking - have taken on many new roles in recent years. Now researchers at Saint Louis University and Old Dominion University in Virginia say smartphones can be used to help elderly diabetics manage their health and learn more about their condition.

30 Oct 2009

Case Western Reserve awarded $14.7M to lead study on effects of lowering systolic blood pressure

Case Western Reserve University School of Medicine has received a $14.7 million, nine-year contract from the National Institutes of Health to be one of five institutions to lead a trial to determine if lowering systolic blood pressure in hypertensive patients, without diabetes, to below the currently recommended level can reduce the incidence of cardiovascular and kidney disease and slow cognitive decline.

30 Oct 2009

Fiscal 2009 results announced by Helix BioPharma

Helix BioPharma Corp. today announced financial results for the year ended July 31, 2009.

30 Oct 2009

Healthy eating tips for diabetics

A new case of diabetes strikes every 20 seconds. With nearly 24 million Americans of all ages affected by the disease and an additional 57 million at risk for diabetes, diabetes has reached epidemic proportions.(1) If current trends continue, one out of three children will live with diabetes sometime in their future.

30 Oct 2009

Studies on fruit-fly may lead to new treatments for sleep-disorders

New research on the fruit-fly brain points to a possible mechanism by which temperature influences the body clock, according to scientists from Queen Mary, University of London.

30 Oct 2009

Aerobics and resistance training exercise prevent visceral fat gain

A study conducted by exercise physiologists in the University of Alabama at Birmingham (UAB) Department of Human Studies finds that as little as 80 minutes a week of aerobic or resistance training helps not only to prevent weight gain, but also to inhibit a regain of harmful visceral fat one year after weight loss.

30 Oct 2009

UNFPA maternal health conferences wrap up

Two United Nations Population Fund (UNFPA) conferences this week in Addis Ababa, Ethiopia, gathered "international policymakers, government ministers, and lawmakers" to address the half a million maternal deaths annually, Radio Free Europe/Radio Liberty reports. Although the U.N. "hopes to reduce maternal mortality by three quarters between 1990 and 2015," this Millennium Development Goal target "has seen the least progress in recent years," the news organization writes.

29 Oct 2009

Inhibitex completes $23 million private placement of common stock and warrants

Inhibitex, Inc. today reported the completion of its previously announced $23 million private placement of common stock and warrants. Investors in the private placement purchased units, each consisting of one share of common stock and a warrant to purchase .45 of a share of common stock, at a purchase price of $1.28 per unit, which is equal to the consolidated closing bid price of the common stock as reported on the NASDAQ Capital Market for October 22, 2009, plus $0.06.

29 Oct 2009

Interleukin Genetics and Amway Global sign partnership agreement

Interleukin Genetics, Inc. announced today it has entered into an agreement with Amway Global. With this agreement, Amway Global Independent Business Owners will be able to sell Interleukin Genetics' Inherent Health(TM) brand of genetic tests, including the new Weight Management Genetic Test.

29 Oct 2009

Neogenomics declares third quarter 2009 financial results; significantly improved liquidity position

NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter of 2009.

29 Oct 2009

EB Sport announces the availability two branded fitness kits for men and women

EB Sport Group, a market leader in the creation of personal exercise and fitness products, has announced the availability of the Men’s Health “Ultimate Total-Body Workout” and Women’s Health “Lean Body Workout” – two branded fitness kits designed to get people back in shape quickly.

29 Oct 2009